David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 30,443 shares at $32.75 ($994K) on 2026-01-13, disclosed to the SEC on 2026-01-15.
Open-market sale of $994k MLYS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 7,709 | $252K | 25.4% |
| 2 | $32.61 | 11,367 | $371K | 37.3% |
| 3 | $32.61 | 11,367 | $371K | 37.3% |
| Total | $32.64 avg | 30,443 | $994K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |